Impact of comorbidity on the outcome in men with advanced prostate cancer treated with docetaxel

BACKGROUND: Men with metastatic castrate-resistant prostate cancer (mCRPC) may not receive docetaxel in everyday clinical practice due to comorbidities. Here we explore the impact of comorbidity on outcome in men with mCRPC treated with docetaxel in a population-based outcome study. METHODS: Men wit...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Radiol Oncol
Hauptverfasser: Zist, Andrej, Amir, Eitan, Ocana, Alberto F., Seruga, Bostjan
Format: Artigo
Sprache:Inglês
Veröffentlicht: Versita, Warsaw 2015
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4722932/
https://ncbi.nlm.nih.gov/pubmed/26834528
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1515/raon-2015-0038
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge